
|Videos|July 23, 2018
How Can Specialty Pharmacies Prepare for New Orphan Drugs?
Joy Gilbert, vice president of operations at US Bioservices, gives advice about how specialty pharmacies need to prepare for new drug approvals.
Advertisement
Joy Gilbert, vice president of operations at US Bioservices, a part of AmerisourceBergen, gives advice about how specialty pharmacies need to prepare for new drug approvals.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
Evolving Mortality Trends in Heart Failure and Vascular Disease: The Critical Role of Pharmacists in Addressing Cardiovascular Risk
3
Targeting Mitochondrial Metabolism in Heart Failure: From Genetic Drivers to Fuel Modulation Therapies
4
Frequent Continuous Glucose Monitoring Linked to Greater HbA1C Reductions in Adults With T2D
5












































































































































































































